# A Study of the HSP90 Inhibitor AUY922

> **NCT01485536** · PHASE2 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 21 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** AUY922

## Key facts

- **NCT ID:** NCT01485536
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Study halted early due to limited response.
- **Last updated:** 2017-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01485536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01485536, "A Study of the HSP90 Inhibitor AUY922". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01485536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*